Efficacy of Bi-level ESPB Application in Patients Undergoing VATS
Pain, Postoperative, Thoracic Surgery, Video-Assisted, Erector Spinae Plane Block
About this trial
This is an interventional treatment trial for Pain, Postoperative
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 80 years
- American Society of Anesthesiologists physical status I-II-III
- Body mass index between 18-40 kg/m2
- Patients undergoing elective video-assisted thoracoscopic surgery
Exclusion Criteria:
- Patient refusing the procedure
- History of chronic analgesic or opioid therapy
- History of local anesthetic allergy
- Infection in the intervention area
- Emergency surgery
Sites / Locations
- Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital
- Ankara City Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
One-level Erector Spinae Plane Block
Bi-level Erector Spinae Plane Block
After the linear ultrasound (US) probe will be placed 2-3 cm lateral to the T5 spinous process, 30 ml of 0.25% bupivacaine hydrochloride will be injected cauda-cranially into the interfacial space below the erector spinae muscle, above the transverse process.
After the linear ultrasound (US) probe will be placed 2-3 cm lateral to the T4 spinous process, 15 ml of 0.25% bupivacaine hydrochloride will be injected cauda-cranially into the interfacial space below the erector spinae muscle, above the transverse process. Next, the needle will be withdrawn till subcutaneously and the linear US probe will be placed 2-3 cm lateral to the T6 spinous process. Finally, 15 ml of 0.25% bupivacaine hydrochloride will be injected cranio-caudally into the interfacial space below the erector spinae muscle, above the transverse process.